Clinical Trial Update: MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial update for MC1R-targeted alpha-particle monotherapy, with a nivolumab combination, in adults with advanced melanoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MC1R-targeted alpha-particle monotherapy
• nivolumab (nivolumab)

Snippet

Sponsor: Perspective Therapeutics | Conditions: Recurrent Melanoma (Skin), Metastatic Melanoma | Phase 1, Phase 2 | Status: RECRUITING